These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 6492527)

  • 1. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. II. Results of a long-term follow-up and technical problems].
    Kumon H; Nasu Y; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):731-8. PubMed ID: 6492527
    [No Abstract]   [Full Text] [Related]  

  • 2. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. III. Detection by PAP method and a classification of staining pattern].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1984 May; 75(5):739-43. PubMed ID: 6208400
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on blood group isoantigens in uroepithelium. I. Determination of isoantigens in non-malignant epithelium of tumor-bearing bladder].
    Abe R
    Nihon Hinyokika Gakkai Zasshi; 1985 Jul; 76(7):1049-58. PubMed ID: 4079195
    [No Abstract]   [Full Text] [Related]  

  • 4. [The study of the ABH isoantigen of bladder tumors].
    Fukatsu H; Nonomura H; Miyagawa Y; Waki M; Hatano Y; Hiraiwa S; Muramatsu T; Takamura T; Yamada Y; Nishikawa E
    Hinyokika Kiyo; 1987 Jun; 33(6):857-63. PubMed ID: 3314420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. IV. Correlation with Thomsen-Friedenreich antigen and CEA].
    Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1986 Sep; 77(9):1511-8. PubMed ID: 3807094
    [No Abstract]   [Full Text] [Related]  

  • 6. A modified immunoperoxidase method for the detection of ABH tissue isoantigens in patients with bladder carcinoma.
    Stul MS; Logghe GN; Bergmans GB; Vanvuchelen JK
    Exp Pathol; 1985; 27(2):119-22. PubMed ID: 3888650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation of ABH antigenicity and urine cytology results in transitional cell carcinoma of bladder.
    Gorelick JI; Oyasu R; Golmon ME; Grayhack JT
    Urology; 1984 Sep; 24(3):287-90. PubMed ID: 6474644
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changing expression of ABH blood group and cryptic T-antigens of noninvasive and superficially invasive papillary transitional cell carcinoma of the bladder from initial occurrence to malignant progression.
    Yamada T; Fukui I; Yokokawa M; Oshima H
    Cancer; 1988 Feb; 61(4):721-6. PubMed ID: 3338034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative analysis of the A, B and H isoantigens in single transitional carcinoma cells.
    Borgström E; Wahren B
    J Urol; 1985 Jul; 134(1):199-202. PubMed ID: 3892047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of ABH blood group isoantigen as a prognostic factor in transitional cell bladder carcinoma.
    Malmström PU; Busch C; Norlen BJ; Andersson B
    Scand J Urol Nephrol; 1988; 22(4):265-70. PubMed ID: 3238331
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of ABH antigenicity of random mucosal biopsies and transitional cell carcinoma of the urinary bladder.
    Jakse G; Hofstädter F
    Eur Urol; 1983; 9(2):97-101. PubMed ID: 6852091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood group isoantigens ABO (H) in transitional carcinoma of the bladder: a clinicopathological study.
    Cuadrado E; Rodriguez-Trinidad A; Blasco E; Torrado J; Lopez Garcia JA; Arozena F
    J Urol; 1986 Feb; 135(2):409-15. PubMed ID: 3511295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic factors for progression of superficial bladder cancer].
    Sato N; Sumiya H; Isaka S; Shimazaki J; Matsuzaki O
    Nihon Hinyokika Gakkai Zasshi; 1992 Aug; 83(8):1263-9. PubMed ID: 1405165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABH isoantigens in bladder carcinoma patients grouped according to DNA changes over time.
    Borgström E; Gustafson H
    Scand J Urol Nephrol; 1987; 21(2):125-30. PubMed ID: 3616504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneic expression of blood group A and H isoantigens in bladder tumors: association with nuclear volume.
    Orntoft TF; Nielsen K
    J Histochem Cytochem; 1989 Jul; 37(7):1153-5. PubMed ID: 2732458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of blood group surface antigens of urinary bladder tumours using monoclonal antibodies with the avidin-biotin complex technique.
    Tan LB; Chiang C; Huang CH; Lin LM
    Int Urol Nephrol; 1992; 24(3):255-64. PubMed ID: 1399382
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABH cell surface isoantigens in invasive bladder carcinoma associated with schistosomiasis.
    El Adl MM; Yamase HT; Nieh PT; Mostofa AS; Hinz CF; Walzak MP
    J Urol; 1984 Feb; 131(2):249-51. PubMed ID: 6366249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Correlations between grading and presence of blood group isoantigens in papillary urothelial-cell carcinoma of the bladder with low grade malignancy].
    Mattarozzi A; Zanella L; Bacchini P; Bertoni F; Ferramosca B
    Pathologica; 1985; 77(1050):395-400. PubMed ID: 3834371
    [No Abstract]   [Full Text] [Related]  

  • 19. [Isoantigens ABH in bladder tumors as an indicator of malignant potential. The staining pattern by PAP method and its correlation with prognosis].
    Saegusa M; Nasu Y; Kumon H; Matsumura Y; Ohmori H
    Nihon Hinyokika Gakkai Zasshi; 1990 Feb; 81(2):196-203. PubMed ID: 1691319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prediction of invasive potential in superficial transitional cell carcinoma of the bladder.
    Finan PJ; Anderson JR; Doyle PT; Lennox ES; Bleehen NM
    Br J Urol; 1982 Dec; 54(6):720-5. PubMed ID: 6758916
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.